Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls.

McIntyre JA, Wagenknecht DR, Ramsey CJ.

Autoimmunity. 2009;42(8):646-52. doi: 10.3109/08916930903074833.

PMID:
19886736
2.

Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.

McIntyre JA, Chapman J, Shavit E, Hamilton RL, Dekosky ST.

Autoimmunity. 2007 Jul;40(5):390-6.

PMID:
17612901
3.

Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease.

McIntyre JA, Ramsey CJ, Gitter BD, Saykin AJ, Wagenknecht DR, Hyslop PA; Alzheimer’s Disease Neuroimaging Initiative.

Autoimmunity. 2015;48(5):344-51. doi: 10.3109/08916934.2015.1008464. Epub 2015 Feb 12.

4.

Redox-reactive autoantibodies in cerebrospinal fluids.

McIntyre JA, Hamilton RL, DeKosky ST.

Ann N Y Acad Sci. 2007 Aug;1109:296-302.

PMID:
17785318
7.

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease.

Tanaka J, Nakamura K, Takeda M, Tada K, Suzuki H, Morita H, Okado T, Hariguchi S, Nishimura T.

Acta Neurol Scand. 1989 Dec;80(6):554-60.

PMID:
2618583
8.

Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.

Korolainen MA, Pirttilä T.

Acta Neurol Scand. 2009 Jan;119(1):32-8. doi: 10.1111/j.1600-0404.2008.01057.x. Epub 2008 Jun 10.

PMID:
18547271
9.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
10.

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Mecocci P, MacGarvey U, Beal MF.

Ann Neurol. 1994 Nov;36(5):747-51.

PMID:
7979220
11.

Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease.

Kadioglu E, Sardas S, Aslan S, Isik E, Esat Karakaya A.

Biomarkers. 2004 Mar-Apr;9(2):203-9.

PMID:
15370876
12.

Serum auto-antibodies in Alzheimer's disease.

Lopez OL, Rabin BS, Huff FJ.

Acta Neurol Scand. 1991 Nov;84(5):441-4.

PMID:
1776393
13.

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.

Abdullah L, Paris D, Luis C, Quadros A, Parrish J, Valdes L, Keegan AP, Mathura V, Crawford F, Mullan M.

Neurosci Lett. 2007 Nov 27;428(2-3):53-8. Epub 2007 Oct 2.

PMID:
17964720
14.

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.

Levin EC, Acharya NK, Han M, Zavareh SB, Sedeyn JC, Venkataraman V, Nagele RG.

Brain Res. 2010 Jul 23;1345:221-32. doi: 10.1016/j.brainres.2010.05.038. Epub 2010 Jun 11.

PMID:
20546711
15.

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

Angelis P, Scharf S, Mander A, Vajda F, Christophidis N.

Neurosci Lett. 1998 Mar 13;244(2):106-8.

PMID:
9572596
16.

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K.

J Psychiatr Res. 2007 Aug;41(5):387-94. Epub 2006 Mar 22.

PMID:
16554070
17.

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, Tanzi RE.

J Biol Chem. 2005 Apr 29;280(17):17458-63. Epub 2005 Feb 21.

18.

Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias.

Schott K, Wormstall H, Dietrich M, Klein R, Batra A.

Psychiatry Res. 1996 Jan 31;59(3):251-4.

PMID:
8930031
19.

Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.

Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Llorca J, Infante J, García-Gorostiaga I, Berciano J, Combarros O.

Acta Neurol Scand. 2007 Dec;116(6):409-12.

PMID:
17986101
20.

Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.

Xu W, Kawarabayashi T, Matsubara E, Deguchi K, Murakami T, Harigaya Y, Ikeda M, Amari M, Kuwano R, Abe K, Shoji M.

Brain Res. 2008 Jul 11;1219:169-79. doi: 10.1016/j.brainres.2008.02.060. Epub 2008 Mar 4.

PMID:
18534566

Supplemental Content

Support Center